Trials / Sponsors / Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | TPN-101 in Aicardi-Goutières Syndrome (AGS) Aicardi-Goutières Syndrome (AGS) | Phase 2 | 2023-03-15 |
| Completed | A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) Progressive Supranuclear Palsy | Phase 2 | 2021-12-12 |
| Completed | A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD Amyotrophic Lateral Sclerosis, Frontotemporal Dementia | Phase 2 | 2021-10-01 |